📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A multicentre randomiSed controlled TRial of IntraVEnous immunoglobulin compared with standard therapy for the treatment of transverse myelitis in adults and children (STRIVE). (2017)

First Author: Absoud M

Attributed to: MRC Centre for Neuropsychiatric Genetics and Genomics funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3310/hta21310

PubMed Identifier: 28639937

Publication URI: http://europepmc.org/abstract/MED/28639937

Type: Journal Article/Review

Volume: 21

Parent Publication: Health technology assessment (Winchester, England)

Issue: 31

ISSN: 1366-5278